# Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness

> **NCT05394545** · NA · SUSPENDED · sponsor: **Nu-Life Solutions** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Pain
- Anxiety
- Depression
- Sleeplessness

## Interventions

- **DEVICE:** Nu-V3

## Key facts

- **NCT ID:** NCT05394545
- **Lead sponsor:** Nu-Life Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-03-20
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** staffing challenges
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394545, "Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05394545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*